title: Free prostate-specific antigen in serum is becoming more complex.
authors.affiliation: Hybritech Incorporated, San Diego, California 92121, USA.
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Mikolajczyk
authors.forename: Leonard S
authors.initials: LS
authors.lastname: Marks
authors.forename: Alan W
authors.initials: AW
authors.lastname: Partin
authors.forename: Harry G
authors.initials: HG
authors.lastname: Rittenhouse
mesh_terms: D000911:Antibodies, Monoclonal; D006801:Humans; D008297:Male; D011467:Prostate / Q000737:chemistry; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000737:chemistry; D011470:Prostatic Hyperplasia / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000737:chemistry; D011498:Protein Precursors / Q000097:blood* / Q000737:chemistry; D012661:Semen / Q000737:chemistry; D012680:Sensitivity and Specificity; D000514:alpha 1-Antichymotrypsin / Q000032:analysis
chemical_list: D000911:Antibodies, Monoclonal; D011498:Protein Precursors; D000514:alpha 1-Antichymotrypsin; D017430:Prostate-Specific Antigen